Prophylaxis and continuous infusion for hemophilia: Can we afford it?

Blood Coagulation and Fibrinolysis

Volumn 7, Issue SUPPL. 1, 1996, Pages

  Aledort, L M ^a   Bohn, R L ^b  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Hemophilia; Joint and X ray score; Orthopedic outcome prophylaxis

Indexed keywords

BLOOD CLOTTING FACTOR 8;

BLEEDING; CLINICAL TRIAL; CONFERENCE PAPER; CONTINUOUS INFUSION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; HEMOPHILIA; HUMAN; MAJOR CLINICAL STUDY; MULTICENTER STUDY; ORTHOPEDICS; PRIORITY JOURNAL;

COST-BENEFIT ANALYSIS; FACTOR VIII; HEMOPHILIA A; HEMORRHAGE; HUMANS; INFUSION PUMPS; JOINT DISEASES;

EID: 0030000014     PISSN: 09575235     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (5)

1. Bjorkman S, Carlsson M, Berntorp E, Stenberg P: Pharmacokinetics of factor VIII in humans. Clin Pharmacokinet 1992, 22:385-395.
2. Kernoff P: Current Factor VIII Usage Related to Self Sufficiency: A European Overview. Factor VIII: Purity and Prophylaxis, Roundtable Series No 25. London: Royal Society of Medicine Services; 1991.
3. Aledort LM, Haschemeyer RH, Pettersson H: A longitudinal study of orthopedic outcomes for severe factor VIII deficient hemophiliacs. J Intern Med 1994, 236:391-399.
4. Pettersson H, Gilbert M: Musculoskeletal and other haemorrhagic complications. In: Diagnostic Imaging in Hemophilia. Berlin: Springer-Verlag; 1985:55-60.
5. Ljung RCR, Lindgren A-C, Tengborn L, Petrini P: Issues in prophylaxis for young children in Sweden: the long-term feasibility of venous access. In: Prophylactic treatment of hemophilia A and B: current and future perspectives. New York: Science and Medicine; 1994:49-51.